ROCKWELL MEDICAL, INC. Deferred Tax Assets, Gross
ROCKWELL MEDICAL, INC. (RMTI) had Deferred Tax Assets, Gross of $85.70 million as of 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsGross · last filed 2026-03-26
- 2025-12-31: Deferred Tax Assets, Gross $85.70M.
- 2024-12-31: Deferred Tax Assets, Gross $85.86M.
- 2023-12-31: Deferred Tax Assets, Gross $90.45M.
- 2022-12-31: Deferred Tax Assets, Gross $88.82M.
| Period end | Deferred Tax Assets, Gross |
|---|---|
| 2025-12-31 | $85.70M 10-K · filed 2026-03-26 |
| 2024-12-31 | $85.86M 10-K · filed 2026-03-26 |
| 2023-12-31 | $90.45M 10-K · filed 2025-03-20 |
| 2022-12-31 | $88.82M 10-K · filed 2024-03-21 |
| 2021-12-31 | $84.47M 10-K · filed 2023-03-30 |
| 2020-12-31 | $77.61M 10-K · filed 2022-04-08 |
| 2019-12-31 | $71.26M 10-K · filed 2021-03-31 |
| 2018-12-31 | $63.72M 10-K · filed 2020-03-17 |
| 2017-12-31 | $51.73M 10-K · filed 2019-03-18 |
| 2016-12-31 | $72.95M 10-K · filed 2018-03-15 |
| 2015-12-31 | $69.30M 10-K · filed 2017-03-15 |
| 2014-12-31 | $69.56M 10-K · filed 2016-02-29 |
| 2013-12-31 | $56.74M 10-K · filed 2015-03-03 |
| 2012-12-31 | $38.81M 10-K · filed 2014-03-07 |
| 2011-12-31 | $20.35M 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |